Autopsy report · NCT00046202
Study of Inborn Errors of Cholesterol Synthesis and Related Disorders
Cause of deathSlow enrollment
“Study terminated due to low enrollment and availability of alternative protocols.”
Life of this trial
- Ran for about 21 years 1 month before it stopped.
- 344 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Sponsor type
- US National Institutes of Health
- Conditions
- Lysosomal Storage Disease; Cholesterol Metabolism
- Participants
- 344
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study
“Study has been terminated and replaced due to low enrollment.” - Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)
“Study terminated due to low enrollment.” - BRIM-P: A Study of Vemurafenib in Pediatric Patients With Stage IIIC or Stage IV Melanoma Harboring BRAFV600 Mutations
“Study was terminated due to low enrollment.” - Evaluation of the Consumption of a Probiotic on the Load of S. Agalactiae.
“The study was terminated due to low enrollment” - Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive Disease
“This study was terminated due to low participant enrollment.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.